Marinus Pharmaceuticals Provides Business Reports Update and 2019 Financial Results

NEXT STORY
Beyond Air Submits Investigational Device Exemption (IDE) to the United States Food and Drug Administration (FDA) for the Treatment of COVID-19 Patients
PREV STORY
Grokker Extends Free Access to Companies to Support Workforce Wellbeing During COVID-19 Outbreak
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Equillium Appoints Industry Veteran, Dolca Thomas, M.D. as Executive Vice President of Research & Development and Chief Medical Officer

author_avatar
NASDAQ Market News

Corvus Pharmaceuticals Announces Third Quarter Financial Results and Provides Business Update

BURLINGAME, Calif., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage ...

author_avatar
NASDAQ Market News

Biomerica Signs Exclusive Distribution Agreement in Canada for its New and Proprietary Helicobacter Pylori (H. pylori) Test, hp+detect™

author_avatar
NASDAQ Market News